Latest from the Blog
OB Pharmaceuticals announces its poster presentation at the annual meeting of the American Epilepsy Society
TORONTO, ONTARIO – December 4, 2020 – OB Pharmaceuticals, Inc., announced today the company will present its poster on... Read More
OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski
LONDON, ONTARIO June 12, 2020 — OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski to Chief Scientific Advisor... Read More